Oxford Immunotec Global PLC Shares Up 10% After Co. Announces Quarterly Financial Results; EPS $(0.25), Inline, Sales $29.318M Beat $28.55M Estimate; Co. Also Announced Launch Of T-Cell Select In Europe
Benzinga Newsdesk